The first new tuberculosis vaccine in a century is heading for mass production. India’s Serum Institute will manufacture M72/AS01E under an agreement with the Gates Medical Research Institute, investing more than $100 million ahead of approval. TB still kills 1.23 million people a year. WHO estimates a vaccine with this efficacy profile could prevent 76 million cases and save 8.5 million lives over 25 years. Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/indias-serum-institute-partners-with-gates-mri-make-expiremental-tb-vaccine-2026-07-16/ #ShareGoodNewsToo